184 related articles for article (PubMed ID: 38456506)
1. Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells.
Donsante S; Pievani A; Palmisano B; Finamore M; Fazio G; Corsi A; Biondi A; Tomatsu S; Piazza R; Serafini M; Riminucci M
JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456506
[TBL] [Abstract][Full Text] [Related]
2. Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease.
Hampe CS; Polgreen LE; Lund TC; McIvor RS
Pediatr Endocrinol Rev; 2020 Aug; 17(4):317-326. PubMed ID: 32780955
[TBL] [Abstract][Full Text] [Related]
3. Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation.
Gatto F; Redaelli D; Salvadè A; Marzorati S; Sacchetti B; Ferina C; Roobrouck VD; Bertola F; Romano M; Villani G; Antolini L; Rovelli A; Verfaillie CM; Biondi A; Riminucci M; Bianco P; Serafini M
Stem Cells Dev; 2012 Jun; 21(9):1466-77. PubMed ID: 22280094
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).
Tolar J; Park IH; Xia L; Lees CJ; Peacock B; Webber B; McElmurry RT; Eide CR; Orchard PJ; Kyba M; Osborn MJ; Lund TC; Wagner JE; Daley GQ; Blazar BR
Blood; 2011 Jan; 117(3):839-47. PubMed ID: 21037085
[TBL] [Abstract][Full Text] [Related]
5. Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I.
Baxter MA; Wynn RF; Deakin JA; Bellantuono I; Edington KG; Cooper A; Besley GT; Church HJ; Wraith JE; Carr TF; Fairbairn LJ
Blood; 2002 Mar; 99(5):1857-9. PubMed ID: 11861306
[TBL] [Abstract][Full Text] [Related]
6. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.
Pievani A; Azario I; Antolini L; Shimada T; Patel P; Remoli C; Rambaldi B; Valsecchi MG; Riminucci M; Biondi A; Tomatsu S; Serafini M
Blood; 2015 Mar; 125(10):1662-71. PubMed ID: 25298037
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
8. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.
Wraith JE
J Inherit Metab Dis; 2001 Apr; 24(2):245-50. PubMed ID: 11405343
[TBL] [Abstract][Full Text] [Related]
10. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
11. Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H.
Raymond GV; Pasquali M; Polgreen LE; Dickson PI; Miller WP; Orchard PJ; Lund TC
Sci Rep; 2016 Dec; 6():38305. PubMed ID: 27910891
[TBL] [Abstract][Full Text] [Related]
12. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
Baxter MA; Wynn RF; Schyma L; Holmes DK; Wraith JE; Fairbairn LJ; Bellantuono I
J Inherit Metab Dis; 2005; 28(6):1045-53. PubMed ID: 16435198
[TBL] [Abstract][Full Text] [Related]
13. Lipid composition of whole brain and cerebellum in Hurler syndrome (MPS IH) mice.
Heinecke KA; Peacock BN; Blazar BR; Tolar J; Seyfried TN
Neurochem Res; 2011 Sep; 36(9):1669-76. PubMed ID: 21253856
[TBL] [Abstract][Full Text] [Related]
14. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs.
Lau YK; Peck SH; Arginteanu T; Wu M; Lin M; Shore EM; Klein PS; Casal ML; Smith LJ
Bone; 2022 Jan; 154():116237. PubMed ID: 34695616
[TBL] [Abstract][Full Text] [Related]
15. Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population.
Chkioua L; Khedhiri S; Ben Turkia H; Chahed H; Ferchichi S; Ben Dridi MF; Laradi S; Miled A
Diagn Pathol; 2011 Nov; 6():113. PubMed ID: 22074387
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
17. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model.
Visigalli I; Delai S; Politi LS; Di Domenico C; Cerri F; Mrak E; D'Isa R; Ungaro D; Stok M; Sanvito F; Mariani E; Staszewsky L; Godi C; Russo I; Cecere F; Del Carro U; Rubinacci A; Brambilla R; Quattrini A; Di Natale P; Ponder K; Naldini L; Biffi A
Blood; 2010 Dec; 116(24):5130-9. PubMed ID: 20847202
[TBL] [Abstract][Full Text] [Related]
19. The importance of skeletal x-ray screening for dysostosis multiplex in the early diagnosis of mucopolysaccharidosis.
Bilgin H; Ayaz E
Clin Imaging; 2024 Jan; 105():110018. PubMed ID: 37984022
[TBL] [Abstract][Full Text] [Related]
20. A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I.
Prommajan K; Ausavarat S; Srichomthong C; Puangsricharern V; Suphapeetiporn K; Shotelersuk V
Mol Vis; 2011 Feb; 17():456-60. PubMed ID: 21364962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
